Chapter 52. Maintenance Immunosuppression

  1. Donald A. Molony MD2,3 and
  2. Jonathan C. Craig MD, PhD4,5
  1. Yves Vanrenterghem MD

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch52

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Vanrenterghem, Y. (2008) Maintenance Immunosuppression, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch52

Editor Information

  1. 2

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 3

    Houston Medical School, Houston, Texas, USA

  3. 4

    School of Public Health, University of Sydney, Australia

  4. 5

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. Department of Nephrology, University Hospital Gasthuisberg, Leuven, Belgium

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391



  • maintenance immunosuppression;
  • maintenance immunosuppression without corticosteroids;
  • Collaborative Transplant Study (CTS);
  • immunosuppressive agents used in solid organ transplantation;
  • Tacrolimus–mycophenolate mofetil–corticosteroids;
  • calcineurin inhibitor (CNI)


This chapter contains sections titled:

  • Introduction

  • Tacrolimus-mycophenolate mofetil-corticosteroids: the current standard of maintenance immunosuppression

  • Maintenance immunosuppression without corticosteroids

  • Maintenance immunosuppression without CNIs

  • References